The Foxo platform enables doctors, clinical teams, and their professional network with modern technology designed to circumvent faxing, phone tag, email, and unsanctioned WhatsApp messaging. The Company is already supporting thousands of clinical and clerical users within 25 organisations across Australia.
The Pen CS Topbar is a clinical decision support platform designed to assist medical practitioners at the point of care by enabling them to make better, data-driven decisions. With Foxo now available on Topbar, the joint offering enables healthcare providers immediate access to their entire healthcare ecosystem to conduct secure instant messaging, video calls, referrals, and bookings.
In Australia, inefficiencies relating to communication issues can cost the average GP in excess of $57,000 per year, contribute to 30% of total malpractice claims, and up to 70% of hospital incidents. The recent integration will play a key role in minimising such problems for Australian healthcare providers.
“Foxo’s mission is to solve the fragmented, insecure, and time-consuming reality that clinical practices face when it comes to referrals, and internal and external communication, between teams and their wider network,” said Luke Fletcher, CEO and Co-Founder, Foxo.
“Accessing the Foxo App through Topbar, and removing the need to leave the patient management system, makes these tasks far more time efficient, saving healthcare providers up to 15 minutes per day. Our strategic partnership with Pen CS means that Foxo can support the thousands of healthcare providers looking for a secure and seamless way to engage and communicate with clinical stakeholders, ensuring appropriate consent,” said Fletcher.
“Topbar is designed to improve patient outcomes and save time, reduce costs, and improve workflow for healthcare providers. The Foxo App presents a new opportunity for healthcare providers as it facilitates effective, consented communication – for e-referrals, for example – within the healthcare providers’ own network for the benefit of their patients,” said Edweana Wenkart, CEO, Pen CS.
Read more about the Foxo and Pen CS partnership at www.foxo.com/topbar.
Learn more about Foxo App on Topbar at https://help.pencs.com.au/display/TUG/Foxo+App.